Release Date: 02/05/11 11:21 Summary: March Quarter Activities Report and Appendix 5b Price Sensitive: No Download Document 617.68KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%